[Age as a prognostic factor in colorectal cancer treatment].

Przegl Lek

I Katedra i Klinika Chirurgii Ogólnej i Klinika Chirurgii Gastroenterologicznej, Collegium Medicum, Uniwersytetu Jagiellońskiego w Krakowie.

Published: November 2006

Aging of the population leads to increasing the numbers of patients requiring surgical interventions. Though highest incidence of colorectal cancer occurs in the age range between 60-70 years, the incidence of colorectal cancer in the age group below 40 years has been also increasing. In this age group the course of the disease and prognosis are different than in the patients over 60 years of age. The authors are analysing data from the study protocols of 1332 patients operated for colorectal cancer at our Department of Surgery between 1984-2000. The results obtained in 3 age groups were compared: group I--patients < or = 40 years (n = 56), group II patients between 41-70 years (n = 944), group III > 70 years (n = 332). No significant differences related to the stage of the disease and the number of asymptomatic patients were observed between groups. The patients below 40 years had more lesions of multiple type, and the number of emergency procedures was lower. The number of resective procedures was the highest in this group similarly as the rates of recurrent disease, either local or systemic. The patterns of five-year survival in the age group below 40 years and over 70 were similar. Colorectal cancer in the patients below 40 years of age has poor prognosis, however long-term survivals are similar as in the patients over 70 years. Due to the lack of concomitant diseases in the patients with colorectal cancer below 40 years, prognosis in this group is the worst.

Download full-text PDF

Source

Publication Analysis

Top Keywords

colorectal cancer
24
patients years
16
age group
12
years
11
patients
9
incidence colorectal
8
group
8
group years
8
years age
8
age
7

Similar Publications

Aim: Total proctocolectomy (TPC) is the standard of care for patients with ulcerative colitis (UC) and dysplasia not amenable to endoscopic management. However, the risks of an extensive resection may outweigh the benefits in high-risk surgical patients. Therefore, we performed a systematic review and meta-analysis to assess postoperative outcomes between segmental colectomy (SEG) versus TPC in patients with UC.

View Article and Find Full Text PDF

Replication Study and Meta-Analysis of the Contribution of Seven Genetic Polymorphisms in Immune-Related Genes to the Risk of Gastric and Colorectal Cancers.

Int J Immunogenet

January 2025

Department of Biological Science and Technology, School of Chemistry, Chemical Engineering and Life Sciences, Wuhan University of Technology, Wuhan, Hubei, China.

Recently, it has been realized that immune processes participate in the pathogenesis of human cancers. A large number of genetic polymorphisms in immune-related genes have been extensively examined for their roles in the susceptibility of gastric cancer (GC) and colorectal cancer (CRC), including IL4 gene rs2070874, IL4RA gene rs1801275, IL18 gene rs187238, IL18RAP gene rs917997, IL17A gene rs8193036, IL23R gene rs1884444 and IL23R gene rs10889677. However, there is no consistent conclusion, which calls for further research.

View Article and Find Full Text PDF

Background: Colorectal cancer (CRC) is a major public health concern. Animal models play a crucial role in understanding the disease pathology and development of effective treatment strategies. Chemically induced CRC represents a cornerstone in animal model development; however, due to the presence of different animal species with different genetic backgrounds, it becomes mandatory to study the susceptibility of different mice species to CRC induction by different chemical entities such as 1,2-dimethylhydrazine (DMH).

View Article and Find Full Text PDF

Purpose: Synchronous esophageal (EC) and rectal carcinoma (RC) is a rare and challenging condition, particularly in curative-intended treatment. Especially locally advanced tumors may not be suitable for primary resection and require individual multimodal treatment. This review examines curative-intended management of synchronous EC and RC.

View Article and Find Full Text PDF

Purpose: We aimed to identify the risk factors for severe neutropenia in the early phase of trifluridine-tipiracil (FTD/TPI) treatment, and their impact on overall survival (OS).

Methods: This single-center retrospective study included patients with unresectable metastatic colorectal cancer who were treated with FTD/TPI. The primary endpoint was OS, and the secondary endpoint was severe neutropenia during the first and second cycles of FTD/TPI.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!